3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Neuroendocrine Tumors
130
Gastro-enteropancreatic neuroendocrine tumor
16
Pancreatic Neoplasms
14
Neoplasms
12
Stomach Neoplasms
8
Carcinoma, Neuroendocrine
8
Carcinoid Tumor
8
Prostatic Neoplasms
7
Lung Neoplasms
7
Carcinoma, Hepatocellular
7
Breast Neoplasms
7
Thyroid Neoplasms
6
Melanoma
6
Esophageal Neoplasms
6
Colonic Neoplasms
6
Rectal Neoplasms
5
Pheochromocytoma
5
Neoplasm Metastasis
5
Gastrointestinal Stromal Tumors
5
Carcinoma
5
Adenoma, Islet Cell
5
Adenocarcinoma
5
Testicular Neoplasms
4
Skin Neoplasms
4
Serotonin Syndrome
4
Sarcoma
4
Paraganglioma
4
Liver Neoplasms
4
Kidney Neoplasms
4
Head and Neck Neoplasms
4
Interventions
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Immunotherapy
1
Drug Therapy
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Parotid Neoplasms
×
NET
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled